Annual Cancer Symposium 2016 - incan-mexico.orgincan-mexico.org/cii/cii2016/docs/SSO.pdf · Annual...

Annual Cancer Symposium 2016

Final Program

September 1st to 3rd, 2016

Grand Coral Beach Spa & Resort

Cancún, México

Organization& Scientific Program Committee Society of Surgical Oncology

Daniel G. Coit, MD, FACS

President Society of Surgical Oncology Professor of Surgery

Memorial Sloan Kettering Cancer Center, New York, USA.

Riccardo A. Audisio, MD

President of the European Society of Surgical Oncology Editor in Chief of Surgical Oncology

University of Liverpool, England

Abigail Caudle, MD, MS, FACS

Department of Breast Surgical Oncology MD Anderson Cancer Center

The University of Texas,Houston, Tx

Peter Beitsch, MD Past- President ASBS

University of Dallas, Texas

Claudius Conrad, MD, PhD

Department of Surgical Oncology

MD Anderson Cancer Center The University of Texas, Houston, TX

Yi-Qian Nancy You, MD, MHSc, FACS Associate Professor, Surgical Oncology

MD Anderson Cancer Center, The University of Texas, Houston, TX

Dr. David M. Hyams, MD

Medical Director Desert Surgical Oncology

Eisenhower Medical Center Rancho Mirage, CA.

Mariana Chavez MacGregor, M.D., MSc

Department of Medical Oncology


Sapna Patel, M.D.

Department of Medical Oncology MD Anderson Cancer Center

The University of Texas, Houston, TX

Sandra S Swain, M.D.

Department of Medical Oncology Huntsman Cancer Institute University of Washington

Chandrakanth Are, MD, MBA, FRCS, FACS

Professor, Department of Surgery Surgical Oncology Jerald L & Carolynn J Varner Professor of Surgical Oncology & Global Health

Vice Chair of Education Program Director General Surgery Residency

University of Nebraska Medical Center

Organization& Scientific Program Committee

Instituto Nacional de Cancerología

Abelardo Meneses García, MD Director General


Eduardo E. Cervera Ceballos, MD Director De Docencia


Ángel Herrera Gómez, MD Director General Adjunto Médico Instituto Nacional de Cancerología

Gonzalo Montalvo Esquivel, MD Subdirector de Cirugía


Héctor Martínez Saíd, MD Profesor Titular Del Curso Coordinador de la Clínica

de Melanoma Instituto Nacional de Cancerología

SSO Executive Council

Juan Enrique Bargallo Rocha, MD

Profesor Titular Del Curso Jefe de Departamento Tumores

Mamarios Instituto Nacional de Cancerología

SSO International Member

Sylvia Verónica Villavicencio Valencia, MD

Profesor Titular Del Curso Subdirectora de

Educación Médica Instituto Nacional de Cancerología

SSO International Member

FACULTY

International Professor

Daniel G. Coit, MD, FACS President SSO

Memorial Sloan Kettering Cancer Center, NY, USA. Riccardo A. Audisio, MD

President ESSO

University of Liverpool, England Abigail Caudle, MD, MS, FACS


Peter Beitsch, MD Past- President ASBS

University of Dallas, Texas

Claudius Conrad, MD PhD MD Anderson Cancer Center,

The University of Texas, Houston, TX Yi-Qian Nancy You, MD, MHSc, FACS

MD Anderson Cancer Center,

The University of Texas, Houston, TX Chandrakanth Are, MD, MBA, FRCS, FACS

University of Nebraska David M. Hyams, MD

Eisenhower Medical Center

Rancho Mirage, CA. Sapna Patel, M.D.

MD Anderson Cancer Center, The University of Texas, Houston, TX

Mariana Chavez MacGregor, M.D., MsC MD Anderson Cancer Center,


Sandra S Swain, M.D. MD Anderson Cancer Center,


Latinamerican Professors

Carlomagno Castillero Pinilla, MD Panamá, Panamá

Herbert Castillo Oliva, MD

Guatemala, Guatemala Jorge Rodríguez Bendaña, MD

Tegucigalpa, Honduras Xavier Kon Jara, MD

Portoviejo, Ecuador

Carlos Duarte, MD Bogota, Colombia

National Professors

Miguel Ángel Álvarez Avitia, M.D.

Instituto Nacional de Cancerología José Luis Barrera Franco, M.D.

Centro Oncológico Estatal Issemym, Toluca Paula Anel Cabrera Galeana, M.D.


Salvador Camacho Gutiérrez, M.D. Guadalajara, Jalisco

Jaime Corona Rivera, M.D. Guadalajara, Jalisco

Rubén Cortés González, M.D. Instituto Nacional de Ciencias Médicas y Nutrición “Dr. Salvador Zubirán

Mario Cuéllar Hübbe, M.D.

Instituto Nacional de Cancerología Nereida Esparza Arias, M.D.

Instituto Nacional de Cancerología Guillermo Flores Ayala, M.D.

Guadalajara, Jalisco

Christian H. Flores Balcázar, M.D. Instituto Nacional de Cancerología

José Vicente Fonseca Morales, M.D. Hospital Central Militar

Rolando García Matus, M.D. Hospital Regional de Alta Especialidad de Oaxaca

Dorian Yarih García Ortega, M.D.

Instituto Nacional de Cancerología Amancio Gatica Pérez, M.D.

Centro Médico Nacional “Lic. Manuel Avila Camacho”, IMSS, Puebla Antonio Gómez Pedraza, M.D.


Manuel González Geronis, M.D. Monterrey. Nuevo León

Martín Granados García, M.D. Instituto Nacional de Cancerología

Horacio Noé López Basave, M.D.

Instituto Nacional de Cancerología Raúl Alejandro López Saucedo, M.D.

Instituto Nacional de Cancerología Kuauhyama Luna Ortiz, M.D

Instituto Nacional de Cancerología Pedro Luna Pérez, M.D.

Centro Médico Nacional Siglo XXI, IMSS.

Antonio Maffuz Aziz, M.D. Centro Médico ABC

Rogelio Martínez Macías, M.D. Hospital Ángeles del Pedregal

Jorge Luis Martínez Tlahuel, M.D.


Juan Manuel Medina Castro, M.D. Centro Oncológico Estatal ISSEMYM, Toluca

Heriberto Medina Franco, M.D. Instituto Nacional de Ciencias Médicas y Nutrición “Dr. Salvador Zubirán”

Rafael Medrano Guzmán, M.D. Centro Médico Nacional Siglo XXI, IMSS

Pabel Miranda Aguirre, M.D.

Centro Médico Nacional “20 de Noviembre” ISSSTE Gerardo Miranda Devora M.D.

Instituto Nacional de Cancerología Javier Melchor Rúan, M.D.


Francisco Javier Ochoa Carrillo, M.D. Instituto Nacional de Cancerología.

Alejandro Padilla Rosciano, M.D. Instituto Nacional de Cancerología.

Gregorio Quintero Beuló, M.D. Hospital General de México - Sociedad Mexicana de Oncología, México

María Teresa Ramírez Ugalde, M.D.

Instituto Nacional de Cancerología Carlos Robles Vidal, M.D.

Instituto Nacional de Cancerología Saúl Enrique Rodríguez Ramírez, M.D.

Centro Médico Nacional Siglo XXI, IMSS

Erika B. Ruiz García, M.D. Instituto Nacional de Cancerología

Juan Manuel Ruiz Molina, M.D. Instituto Nacional de Cancerología

Nora Sobrevilla Moreno, M.D.

Instituto Nacional de Cancerología Alberto Tavares de la Paz, M.D.

Hospital Regional de Alta Especialidad del Bajío Rafael Vázquez Romo M.D. MSc

Instituto Nacional de Cancerología Cynthia Villarreal Garza M.D.


CORAL KINGDOM, 2nd Floor

7:00 - 8:30 hrs

M e e t t h e P r o f e s s o r B r e a k f a s t

Pearls in Hepatic and Pancreatic Surgery

Claudius Conrad, MD PhD

Department of Surgical Oncology, MD Anderson Cancer Center,


Javier Melchor Rúan, MD Department of Surgical Oncology, Instituto Nacional de Cancerología

MODERATOR: Juan Manuel Medina Castro, MD Centro Oncológico Estatal ISSEMYM, Toluca

PANEL: Rolando García Matus Hospital Regional de Alta Especialidad de Oaxaca

Carlomagno Castillero Pinilla, MD Panamá, Panamá

Thursday, September 1st

CORAL KINGDOM, 2nd Floor 9:00 - 10:30 hrs

I n a u g u r a l C o n f e r e n c e “Dr. Arturo Beltrán Ortega”

MODERATOR:

Gonzalo Montalvo Esquivel, MD Instituto Nacional de Cancerología

“Global Cancer Surgery: Delivering Safe, Affordable, and Timely

Cancer Surgery” 9:00 – 10:00

Daniel G. Coit, MD, FACS President SSO

Memorial Sloan Kettering Cancer Center, New York, USA.

Discussion

10:00 - 10:30

PANEL: Riccardo Audisio, MD

President European Society of Surgical Oncology - University of Liverpool, England Ángel Herrera Gómez, MD

Instituto Nacional de Cancerología Francisco Javier Ochoa Carrillo, MD Instituto Nacional de Cancerología

Gregorio Quintero Beuló, MD Sociedad Mexicana de Oncología, México

Hector Martínez Saíd, MD President LASSO – Instituto Nacional de Cancerología

CORAL KINGDOM, 2nd floor 10:30 -11:00 hrs

B e s t o f S S O P r e s e n t a t i o n s

Breast Cancer

Abigail Caudle, MD MD Anderson Cancer Center, Houston, Texas

MODERATORS: Carlos Robles Vidal, MD Instituto Nacional de Cancerología Jaime Corona Rivera, MD Guadalajara, Jalisco

The Effect of Event-Free Years on the Risk of 5-Year Local Recurrence in Different Subtypes of

Breast Cancer. M. Moossdorff*, T. van Nijnatten, B. Goorts, E. Heuts, M. Smidt, Maastricht

University Medical Center, Maastricht, NETHERLANDS|R. Bretveld, Netherlands Comprehensive

Cancer Organisation, Utrecht, NETHERLANDS|L.J. Strobbe, Canisius-Wilhelmina Hospital,

Nijmegen, NETHERLANDS|

Combining Clinical and Pathologic Staging Variables with Biologic Factors has Prognostic

Value in Predicting Local-Regional Recurrence Following Neoadjuvant Chemotherapy for

Breast Cancer. J. Vila, S. Tucker, B.D. Smith, M. Chavez MacGregor, K.K. Hunt, E. Mittendorf*,

Breast Surgical Oncology, MD Anderson Cancer Center, Houston, Texas, UNITED STATES|

How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients with

Histologically Confirmed Nodal Metastases? Results of a Prospective Study. A. Mamtani*, A.

Barrio, T.A. King, G. Plitas, K.J. Van Zee, M. Pilewskie, M.B. El-Tamer, M.L. Gemignani, A.S.

Heerdt, L.M. Sclafani, V. Sacchini, H.S. Cody III, M. Morrow, Memorial Sloan Kettering Cancer

Center, New York, New York, UNITED STATES|

Omitting a Re-excision for a Focally Positive Surgical Margin After Primary Breast Conserving

Surgery is Safe. E. Vos*, C. Verhoef, L. Koppert, Erasmus MC Cancer Institute, Rotterdam,

NETHERLANDS|S. Siesling, A. Voogd, Netherlands Comprehensive Cancer Organisation, Utrecht,

NETHERLANDS|

CORAL KINGDOM, 2nd Floor 11:00 -11:30 hrs

Melanoma / Soft Tissue Sarcomas

Daniel Coit, MD Memorial Sloan Katering Center, New York

MODERATORS: Mario Cuéllar Hübbe, MD

Instituto Nacional de Cancerología Raul Alejandro López Saucedo, MD Instituto Nacional de Cancerología

Durable Complete Responses (CRs) in Patients (pts) with Stage IIIB-IV Melanoma Treated with

Talimogene Laherparepvec (T-VEC) in OPTiM R. Andtbacka*, Huntsman Cancer Institute,

University of Utah, Salt Lake City, Utah, UNITED STATES|H. Kaufman, Rutgers Cancer Institute

of New Jersey, New Brunswick, New Jersey, UNITED STATES|F. Collichio, The University of North

Carolina at Chapel Hill, Chapel Hill, North Carolina, UNITED STATES|T. Amatruda, Minnesota

Oncology, Fridley, Minnesota, UNITED STATES|J. Nemunaitis, Mary Crowley Cancer Research

Center, Dallas, Texas, UNITED STATES|J. Chesney, University of Louisville, Louisville, Kentucky,

UNITED STATES|I. Puzanov, Vanderbilt University Medical Center, Nashville, Tennessee, UNITED

STATES|K. Harrington, The Institute of Cancer Research/The Royal Marsden Hospital, London,

England, UNITED KINGDOM|Y. Zhang, L. Chen, M. Shilkrut, Amgen Inc., Thousand Oaks,

California, UNITED STATES|M. Ross, MD Anderson Cancer Center, Houston, Texas, UNITED

STATES|

Impact of Radiation Therapy on Retroperitoneal Sarcoma D. Lee, K.T. Huynh*, R.C. Wollman,

S.L. Stern, L.J. Foshag, A.J. Bilchik, M.B. Faries, M. Goldfarb, John Wayne Cancer Institute, Los

Angeles, California, UNITED STATES|L. Lim, Kaiser Permanente, Los Angeles, California, UNITED

STATES|

Radiation Therapy is Associated with Improved Survival for Retroperitoneal Sarcoma: A

Contemporary Analysis of 9,068 Patients C.N. Rushing, B.L. Peterson, Duke University School of

Medicine Department of Biostatistics & Bioinformatics, Durham, North Carolina, UNITED

STATES| D.P. Nussbaum*, W.O. Lane, D. Blazer, Duke University School of Medicine Department

of Surgery, Durham, North Carolina, UNITED STATES|D.M. Cardona, Duke University School of

Medicine Department of Pathology, Durham, North Carolina, UNITED STATES|D.G. Kirsch, Duke University School of Medicine Department of

Radiation Oncology; Department of Pharmacology and Cancer Biology, Durham, North Carolina,

UNITED STATES|

Is there a Volume-Outcome Relationship for Short and Long-term Outcomes in Soft Tissue

Sarcoma? Results from Analysis of the U.S. National Cancer Data Base S. Bagaria*, R.J. Gray,

S. Attia, J. Ashman, N. Wasif, Surgery, Mayo Clinic, Jacksonville, Florida, UNITED STATES|


Gastrointestinal Cancer

Claudius Conrad / Nancy You MD Anderson Cancer Center, Houston, Texas

MODERATORS: Gerardo Miranda Devora MD

Instituto Nacional de Cancerología Heriberto Medina Franco, MD Instituto Nacional de Ciencias Médicas y Nutrición “Dr. Salvador

Zubirán”

PET-CT Compared to No PET-CT in the Management of Potentially Resectable Colorectal

Cancer Liver Metastases: The Cost Implications of a Randomized Controlled Trial C. Gu, J.

Julian, M.N. Levine, Ontario Clinical Oncology Group, McMaster University, Hamilton, Ontario,

CANADA|C. Moulton, S. Gallinger, Department of Surgery, University of Toronto, Toronto,

Ontario, CANADA|A. Gafni, Department of Clinical Epidemiology and Biostatistics, McMaster

University, Hamilton, Ontario, CANADA| P. Serrano Aybar*, Department of Surgery, McMaster

University, Hamilton, Ontario, CANADA|

Impact of Chemotherapy and External-Beam Radiation Therapy on Outcomes Among Patients

with Resected Gallbladder Cancer: A Multi-Institutional Analysis Y. Kim*, N. Amini, G.A.

Georgios, A. Wilson, T.M. Pawlik, The Johns Hopkins Hospital, Baltimore, Maryland, UNITED

STATES|C.G. Ethun, K. Cardona, S.K. Maithel, Emory University, Atlanta, Georgia, UNITED

STATES|G.A. Poultsides, T. Tran, Stanford University, Stanford, California, UNITED STATES|K.

Idrees, C.A. Isom, Vanderbilt University, Nashville, Tennessee, UNITED STATES|R.C. Fields, B.A.

Krasnick, Washington University, Saint Louis, Missouri, UNITED STATES|S. Weber, A.I. Salem,

University of Wisconsin, Madison, Wisconsin, UNITED STATES|R.C. Martin, C. Scoggins,

University of Louisville, Louisville, Kentucky, UNITED STATES|P. Shen, H. Mogal, Wake Forest

University, Winston-Salem, North Carolina, UNITED STATES|C.R. Schmidt, E.W. Beal, The Ohio

State University, Columbus, Ohio, UNITED STATES|I. Hatzaras, R. Shenoy, New York University,

New York, New York, UNITED STATES|

Development of a Prognostic Model for Patients with Peritoneally Metastasized Colorectal

Cancer Treated with Cytoreductive Surgery and HIPEC G. Simkens*, T. van Oudheusden, H.

Rutten, G. Nieuwenhuijzen, M. Luyer, S. Nienhuijs, I. de Hingh, Surgical Oncology, Catharina

Hospital Eindhoven, Eindhoven, Noord-Brabant, NETHERLANDS|D. Nieboer, E. Steyerberg,

Erasmus MC - University Medical Center, Rotterdam, Zuid-Holland, NETHERLANDS|

Impact of Insurance Expansion on Access to Colorectal Cancer Care A. Loehrer*, D.C. Chang, Z.

Song, M.M. Hutter, J.T. Mullen, Surgery, Massachusetts General Hospital, Boston,

Massachusetts, UNITED STATES|

Treatment of Borderline Resectable (BR) and Locally Advanced (LA) Pancreatic Cancer in the

Era of FOLFIRINOX and Gemcitabine + Nab-Paclitaxel: A Multi-Institutional Study K. Idrees*, A.

Parikh, Surgery, Vanderbilt University, Nashville|Tennessee, UNITED STATES|L.M. Postlewait, S.

Maithel, D.A. Kooby, Emory University, Atlanta, Georgia, UNITED STATES|S. Weber, C.S. Cho,

A.I. Salem, University of Wisconsin, Madison, Wisconsin, UNITED STATES|R.C. Martin, C.

Scoggins, University of Louisville, Louisville, Kentucky, UNITED STATES|H.J. Kim, J. Carr,

University of North Carolina, Chapel Hill, North Carolina, UNITED STATES|B. Xia, S. Ahmad, D.

Abbott, University of Cincinnati, Cincinnati, Ohio, UNITED STATES|N. Merchant, University of

Miami, Miami, Florida, UNITED STATES|

Novel Calculators for Esophageal Adenocarcinoma Accurately Predict which Patients Benefit

from Neoadjuvant Chemoradiation and Estimate Overall Survival E. Gabriel*, K. Attwood, R.

Shah, S. Hochwald, S. Nurkin, M. Kukar, Surgical Oncology, Roswell Park Cancer Institute,

Buffalo, New York, UNITED STATES|

B R E A K

12:00 – 12:30


I n t e r a c t i v e M u l t i d i s c i p l i n a r y C a s e P r e s e n t a t i o n

Colorectal cancer

CLINICAL CASE PRESENTER:

Horacio Noé López Basave, MD Instituto Nacional de Cancerología

PARTICIPANTS: Nancy You, MD MD Anderson Cancer Center, Houston, Texas Juan Manuel Ruiz Molina, MD Instituto Nacional de Cancerología Saúl Rodríguez Ramírez, MD Centro Médico Nacional Siglo XXI Guillermo Flores Ayala, MD Guadalajara, Jalisco Erika B. Ruiz García, MD Instituto Nacional de Cancerología Herbert Castillo Oliva, MD Guatemala, Guatemala



Soft Tissue Sarcomas


Sylvia Verónica Villavicencio Valencia, MD Instituto Nacional de Cancerología PARTICIPANTS: Daniel G. Coit, M.D., FACS Memorial Sloan Kettering, NY, USA Mario Cuéllar Hübbe, MD Instituto Nacional de Cancerología Martín Granados García, M.D. Instituto Nacional de Cancerología Pabel Miranda Aguirre, MD Centro Médico Nacional “20 de Noviembre” ISSSTE Jorge Luis Martínez Tlahuel, MD Instituto Nacional de Cancerología Xavier Kon Jara, MD Portoviejo, Ecuador



Melanoma CLINICAL CASE PRESENTER:

Dorian Yarih García Ortega, MD Instituto Nacional de Cancerología

PARTICIPANTS:

Daniel Coit, M.D. Memorial Sloan Kettering Cancer Center Sapna Patel, M.D. MD Anderson Cancer Center Salvador Camacho Gutiérrez, MD Guadalajara, Jalisco Rogelio Martínez Macias, MD Hospital Angeles del Pedregal Alberto Tavares de la Paz, MD Hospital Regional de Alta Especialidad del Bajío Miguel Ángel Álvarez Avitia, MD Instituto Nacional de Cancerología Carlos Duarte, MD Bogotá, Colombia

B R E A K

14:45 – 15:30


G r e a t D e b a t e s

i n S u r g i c a l O n c o l o g y

Resectable Pancreatic Head Adenocarcinoma: Resect First

15:30 – 16:30

MODERATOR: Alejandro Padilla Rosciano, MD Instituto Nacional de Cancerología.

20´ Con: Claudius Conrad, MD, PhD

M.D. Anderson Cancer Center, Houston, TX.

20´ Pro:

Javier Melchor Ruán, MD Instituto Nacional de Cancerología

20´ Discussion

Colorectal Cancer: Resection of Primary Colorectal Cancer with Unresectable Metastatic Disease

16:30 – 17:30

MODERATOR: Pedro Luna Pérez, MD Centro Médico Nacional Siglo XXI, IMSS.

20´ Pro: Nancy You, MD.

MD Anderson Cancer Center, Houston, Tx.

20´ Con:

Horacio Noé López Basave, MD Instituto Nacional de Cancerología

20´ Discussion

Grand Coral III, 4th Floor

18:00 -21:00 hrs

G r e a t I n a u g u r a l C o n g r e s s C o n f e r e n c e

International Academic Oncology Meeting

The Paradigm of Drug Pricing in Oncology

Hagop Kantarjian M.D.

Music in Medicine

Claudius Conrad, M.D., PhD.

The Best of Society of Surgical Oncology (SSO)

The Best of American Society Clinical Oncology (ASCO)

Hemato-Oncology Conference (HOC)

Selected Topics in Radiotherapy

Palliative Care for Oncology

Selected Topics in Gynecology Oncology

Anesthesia Management and Advanced Topics in Cancer Patients

Cancer Pain Treatment

The Amplatz Conference

Reception Cocktail & Expo Inauguration

Welcome Reception

, Friday September 2nd


7:30 – 9:00 hrs


Genomics for Surgeons

Dr. David M. Hyams, MD

Medical Director Desert Surgical Oncology

Eisenhower Medical Center Rancho Mirage, CA.

MODERATOR: Antonio Gómez Pedraza, MD


PANEL: Rubén Cortés González, MD Instituto Nacional de Ciencias Médicas y Nutrición “Dr. Salvador Zubirán”

Manuel González Geronis, MD Monterrey. N. L.

9:00 – 14:30


S P E C I A L J O I N E D S E S S I O N SOCIETY OF SURGICAL ONCOLOGY (SSO)

AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) EUROPEAN SOCIETY OF SURGICAL ONCOLOGY (ESSO)

“Dr. Jaime G. de la Garza Salazar”MAKING A CHOICE to TAKING A DECISION

Debate: Medical Oncology – Surgical Oncology

Melanoma Metastasic Melanoma: Is there a Role of Surgery in the

New Era? 14:00 – 15:00

MODERATOR:

Héctor Martinez Said, MD Instituto Nacional de Cancerología

PARTICIPANTS:

Sapna Patel, M.D.

Miguel Ángel Álvarez

Avitia, M.D.

Daniel G. Coit, M.D.

S. Verónica Villavicencio

Valencia, M.D.

Kuauhyama Luna Ortiz,

M.D

Nora Sobrevilla

Moreno, M.D.

Breast Cancer Management of Axillary Positive Nodes (1 to 3 nodes) in

Invasive Breast Cancer 15:00 – 16:30

MODERATOR:

Juan Enrique Bargallo Rocha, MD

Instituto Nacional de Cancerología Paula Anel Cabrera Galeana, M.D. Instituto Nacional de Cancerología

PARTICIPANTS:

Riccardo Audisio

Peter Beitsch MD

Mariana Chávez

MacGregor MD

Cynthia Villarreal Garza MD

Sandra Swain MD

Abigail Caudle MD

CORAL KINGDOM, 2nd floor

16:30 -17:15 hrs

Interactive Multidisciplinary Case Presentation Breast Cancer


Nereida Esparza Arias, MD Instituto Nacional de Cancerología PARTICIPANTS: Abigail Caudle, MD MD Anderson Cancer Center, Houston Texas Mariana Chávez Mac Gregor, MD, MSc MD Anderson Cancer Center, Houston Texas Peter Beitsch, MD, FACS Medical City Dallas Hospital Juan Enrique Bargallo Rocha, MD Instituto Nacional de Cancerología Christian H. Flores Balcázar, MD Instituto Nacional de Cancerología Antonio Maffuz Aziz, MD Centro Médico ABC Jorge Rodríguez Bendaña, MD Tegucigalpa, Honduras


The Best of SSO

Closing Conference GLOBAL CURRICULUM FOR SURGICAL

ONCOLOGY TRAINING INTRODUCTION

Ángel Herrera Gómez, M.D.


Riccardo Audisio, M.D.

President of European Society Surgical Oncology

University of Liverpool, England

DISCUSSION: Daniel Coit, M.D.

Memorial Sloan Kattering Cancer Center

Chandrakanth Are, MD, MBA, FRCS, FACS

University of Nebraska

José Luis Barrera Franco, M.D.

Centro Oncológico Estatal Issemym, Toluca

Vicente Fonseca Morales, M.D.

Hospital Central Militar

Rafael Medrano Guzmán, M.D.

Centro Médico Nacional Siglo XXI, IMSS

18:30 – 19:30 hrs

Socialize with collegues in your disease track in a casual Happy Hour

Saturday, September 3rd


7:00 - 8:30 hrs


ACOSOG Z011: Update 2016

Peter Beitsch, M.D. Dallas, Texas

Abigail Caudle, M.D. MD Anderson Cancer Center

Houston, Texas

MODERATOR: Rafael Vázquez Romo, MD, MsC Instituto Nacional de Cancerología

PANEL: Amancio Gatica Pérez, M.D. Centro Médico Nacional “Lic. Manuel Ávila Camacho”, IMSS

María Teresa Ramírez Ugalde, MD Instituto Nacional de Cancerología

9:00 – 15:00

Meeting

Grupo de Investigación en Sarcomas de México

5ª. Reunion del Consenso Nacional ATENCION INTEGRAL EN SARCOMAS

09:00 - 10:00 hrs MODERATOR: Abelardo Meneses García, M.D. Instituto Nacional de Cancerología Mario Cuellar Hübbe, MD

Instituto Nacional de Cancerología PANEL: Héctor Martínez Said, MD


Jorge Luis Martínez Tlahuel, MD Instituto Nacional de Cancerología Sylvia Verónica Villavicencio Valencia, MD Instituto Nacional de Cancerología Dorian Yarih García Ortega, MD Instituto Nacional de Cancerología José Luis Barrera Franco, MD Centro Oncológico Estatal, ISSEMYM, Toluca

Rafael Medrano Guzmán, MD Centro Médico Nacional Siglo XXI, IMSS Pabel Miranda Aguirre, MD Centro Médico Nacional “20 de Noviembre” ISSSTE Alberto Tavares de la Paz, MD Hospital Regional Alta Especialidad del Bajío, Leon,

Guanajuato

The Society of Surgical Oncology Board with representatives of Corea, Brasil, China,

Egypt, Japan, European Community and Mexico.

Be at the Center of Change in Surgical Oncology

Surgical Oncology is experiencing an exciting evolution and the ways in which we treat cancer are changing. How we

approach these changes creates new opportunities—and new questions. SSO 2017 will focus on the treatments of

tomorrow that can be applied to today’s surgical patients with solid tumor cancers while fostering compelling

conversations among our community. But the conversation isn’t complete without you! Join us for the 70th SSO

Annual Cancer Symposium in Seattle, Washington and be among fellow surgical oncology pioneers and leaders.

Along with outstanding networking, you will experience an education program that is unique in its ability to cover a

broad range of important, timely and in-depth topics in one exceptional setting.

• Engage with esteemed colleagues from March 15-18, 2017, at the Washington State Convention Center, Seattle,

Washington.

• Join the brightest minds in surgical oncology from all around the world, including more than 1,500 surgical

oncologists and oncology health care professionals.

• Gain advanced knowledge, expanding your insight and exposure to the newest ideas through a multitude of

presentations and workshops, many led by internationally recognized experts.

• Connect and collaborate with old friends and new as you network between sessions, during scheduled symposium

activities, and at lively informal gatherings throughout the event.

• Learn from two Plenary Sessions, providing you with knowledge that will inspire and invigorate you, given by

authors of the “best-of-the-best” selected abstracts.

• Be inspired by more than 350 compelling and thought-provoking poster sessions, along with late-breaking videos

showcased in the Exhibit Hall.

• Experience first-hand interaction with the latest, most advanced medical equipment, services, and solutions for

surgical oncologists – exhibited by the leading companies in surgical oncology and the treatment of solid tumor

cancers.

Today's Leaders

SSO 2017 expects to welcome 1,800+ total attendees, comprised of both academic and community practitioners and health care professionals from all surgical oncology specialties, treating all disease sites, including: • Breast

• Colorectal

• Endocrine

• Gastrointestinal

• Head and Neck

• Liver and Pancreas

• Sarcomas

• Melanoma

Tomorrow's Innovation

SSO 2017 makes it convenient for attendees to explore a wide range of services and solutions via our top-tier

exhibition. See the latest ideas that medical device, equipment, and technology exhibitors have to offer along with

pharmaceutical companies – all created to enhance the practice of the surgical oncologist

Annual Cancer Symposium 2016 - incan-mexico.orgincan-mexico.org/cii/cii2016/docs/SSO.pdf · Annual...

Documents

Transcript of Annual Cancer Symposium 2016 - incan-mexico.orgincan-mexico.org/cii/cii2016/docs/SSO.pdf · Annual...